Summary
An important characteristic which distinguishes calcium antagonists from traditional vasodilators is their natriuretic rather than antinatriuretic action. Evidence that all classes of calcium antagonists have a natriuretic effect has been provided by intravenous administration in animal experiments.
After single oral doses, all calcium antagonists have some natriuretic effect, but its extent differs with different compounds; dihydropyridines have a greater immediate natriuretic response than verapamil or gallopamil. Recent experiments by our group using the newer dihydropyridine derivative, isradipine, indicate that the natriuretic response may occur at even lower doses than the antihypertensive effect. Indeed, doses of 2.5mg, 5.0mg and 7.5mg of this compound caused an increasingly larger fall in blood pressure, while the natriuretic and diuretic effects peaked with the 2.5mg dose. The natriuretic effect is associated with no or a very small change in glomerular filtration rate and with a more consistent increase in renal plasma flow.
The duration of the natriuretic action of calcium antagonists is debated. Our studies have shown that this action is evident during the first 2 days of administration of a dihydropyridine, and then seems to disappear; however, a small negative sodium balance persists, an observation that accounts for the absence of any increase in bodyweight or fluid volumes with long term administration of calcium antagonists, despite their vasodilating action. Recent data have shown that under long term treatment with isradipine sodium clearance was still increased a few hours after administration.
In conclusion, the persistent natriuretic action of calcium antagonists is capable of maintaining a negative sodium balance and, therefore, is likely to contribute to the long term antihypertensive effect of calcium antagonists, which is primarily due to the vasodilation properties of these compounds.
Similar content being viewed by others
References
Di Bona GF, Sawin LL. Renal tubular site of action of felodipine. Journal of Pharmacology and Experimental Therapeutics 228: 420–424, 1984
Dietz JR, Davis JO, Freeman RH, Villareal D, Echtenkamp SF. Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs. Hypertension 5: 482–488, 1983
Fakunding JL, Catt KJ. Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: effects of lanthanum and verapamil. Endocrinology 107: 1345–1353, 1980
Foster R, Lobo MV, Rasmussen H, Marusic ED. Calcium: its role in the mechanism of action of angiotensin II and potassium in aldosterone production. Endocrinology 109: 2196–2201, 1981
Foster R, Rasmussen H. Angiotensin-mediated calcium efflux from adrenal glomerulosa cells. American Journal of Physiology 245: E281–E287, 1983
Krusell LR, Jespersen LT, Schmitz A, Thomsen K, Lederballe Pedersen O. Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine. Hypertension 10: 577–581, 1987
Lederballe Pedersen O, Krusell LR, Sihm I, Jespersen LT, Thomsen K. Long-term effects of isradipine on blood pressure and renal function. American Journal of Medicine 86(Suppl. 4A): 15–18, 1989
Leonetti G, Bonazzi O, Grazi S, Ligresti A, Romano S, et al. Cardiovascular and renal effects of a new antihypertensive compound, guancydine. European Journal of Clinical Pharmacology 4: 1–9, 1971
Leonetti G, Cuspidi C, Sampieri L, Terzoli L, Zanchetti A. Comparison of cardiovascular, renal and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects. Journal of Cardiovascular Pharmacology 4(Suppl. 3): S319–S324, 1982
Leonetti G, Gradnik R, Terzoli L, Fruscio M, Rupoli L, et al. Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance and renin-angiotensin-aldosterone system in hypertensive patients. Journal of Cardiovascular Pharmacology 8: 1243–1248, 1986
Leonetti G, Rupoli L, Sangiorgio P, Gradnik R, Cuspidi C, et al. Effects of different intakes of sodium on the antihypertensive and renal effects of single oral doses of nifedipine in hypertensive patients. Journal of Cardiovascular Pharmacology 10(Suppl. 10): S138–S139, 1987a
Leonetti G, Terzoli L, Zanchetti A. Calcium antagonists and responsiveness of the adrenal glands to aldosterone-releasing stimuli in hypertensive patients. Journal of Hypertension 5(Suppl. 4): S119–S122, 1987b
MacGregor GA, Pevahouse JB, Cappuccio FP, Markandu ND. Nifedipine, diuretics and sodium balance. Journal of Hypertension 5(Suppl. 4): S127–S131, 1987
Rupoli L, Fruscio M, Gradnik R, Chianca R, Leonetti G, et al. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects. American Journal of Medicine 86(Suppl. 4A): 65–66, 1989
Semplicini A, Pessina AC, Rossi GP, Padrini R, Tagliafierro R, et al. Plasma levels of verapamil and its effects on blood pressure, body fluid volumes and renal function in hypertensive patients. International Journal of Clinical Pharmacological Research 2(Suppl. 1): 81–86, 1982
Zanchetti A. Role of calcium antagonists in systemic hypertension. American Journal of Cardiology 59: 130B–136B, 1987
Zanchetti A, Leonetti G. Natriuretic effect of calcium antagonists. Journal of Cardiovascular Pharmacology 7(Suppl. 4): S33–S37, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zanchetti, A., Leonetti, G. Natriuretic Effects of Calcium Antagonists. Drugs 40 (Suppl 2), 15–21 (1990). https://doi.org/10.2165/00003495-199000402-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199000402-00006